image
Healthcare - Biotechnology - NASDAQ - US
$ 3.61
2.27 %
$ 28.3 M
Market Cap
-6.94
P/E
BALANCE SHEET
43.8 M ASSETS
-2.35%
18.8 M LIABILITIES
29.93%
25 M EQUITY
-17.73%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ImmuCell Corporation
image
Current Assets 11.5 M
Cash & Short-Term Investments 979 K
Receivables 2.19 M
Other Current Assets 8.31 M
Non-Current Assets 32.3 M
Long-Term Investments 0
PP&E 32.1 M
Other Non-Current Assets 191 K
Current Liabilities 4.2 M
Accounts Payable 875 K
Short-Term Debt 2.07 M
Other Current Liabilities 1.25 M
Non-Current Liabilities 14.6 M
Long-Term Debt 14.6 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989
ASSETS
Cash & Cash Equivalents 1.0 5.8 10.2 7.9 8.8 2.5 3.8 5.2 1.6 0.9 2.3 2.7 0.8 1.4 1.0 1.2 1.2 1.3 1.2 1.7 3.4 2.4 1.9 1.9 1.8 1.5 1.0 1.0 1.6 1.3 1.5 1.1 0.8 0.9 0.6
Short Term Investments 0 0 468 1.0 2.5 0 0 5.5 4.5 2.5 3.0 2.2 4.2 3.2 3.6 3.9 4.2 5.3 3.9 2.7 0.9 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.2 1.8 2.7 1.9 1.7 1.4 1.5 1.1 0.7 1.0 0.6 0.6 0.4 0.5 0.4 0.9 0.9 0.6 0.7 0.4 0.4 0.4 1.0 0.9 0.5 0.2 0.7 0.4 0.4 0.4 0.4 0.2 100 K 0.2 0.3
Inventory 7.8 6.0 3.1 2.1 2.5 2.3 2.0 2.1 0.9 0.9 1.2 1.6 1.7 1.6 1.1 0.6 0.6 0.8 0.7 0.7 0.7 0.8 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.5 0.7 0.6 0.4 0.3
Other Current Assets 0.5 0.4 0.3 0.3 0.2 0.1 0.2 0.5 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.3 92 K 0.1 0.1 0.1 27.8 K 100 K 0 100 K 0 0 0.2 100 K 0.2 1.5 2.4
Total Current Assets 11.5 14.0 16.3 12.2 13.2 6.4 7.5 14.3 7.9 5.5 7.3 7.4 7.2 7.0 6.3 6.7 7.1 8.4 6.8 5.8 5.4 4.5 3.5 3.4 2.8 2.3 2.2 2.1 2.6 2.3 2.6 2.1 1.7 3.0 3.6
PP&E 32.1 30.6 28.0 28.0 25.3 26.0 26.1 9.8 5.7 3.8 2.5 2.4 2.5 2.7 3.0 2.9 2.9 1.9 1.8 1.9 1.8 1.7 1.7 0.9 0.8 0.7 0.8 0.8 0.7 0.8 0.5 0.2 0.2 0.3 0.2
Intangible Assets 38.2 K 57.3 K 76.4 K 95.5 K 0.1 0.1 0.2 0.2 0 0 0 0 0 0 900 31.9 K 66.7 K 0.5 0.8 1.1 0.2 0 0.3 0 0 0 0 0 0 0 0 0 100 K 100 K 100 K
Goodwill 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 95.6 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 40.2 K 0 0 0.5 0.5 0 0 0 0 0 0 (265.0) (316.2) (421.2) (459.2) (737.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 57.7 K 76.6 K 26.1 K 26.2 K 26.9 K 53.2 K 920 34.3 K 49.7 K 18.9 K 13.6 K 63.6 K 19 K 34 K 0 0 265.0 316.2 421.2 459.2 737.1 1.3 1.6 2.1 0.3 100 K 0.2 0.2 100 K 0 0 0 0.2 0 100 K
Other Assets 0 351 312 406 164 168 44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 43.8 44.9 44.5 40.4 38.7 32.7 34.3 24.7 14.6 11.1 11.0 11.0 11.0 10.8 10.0 10.1 10.4 11.4 10.0 9.5 8.2 7.5 7.1 6.4 3.9 3.1 3.2 3.1 3.2 3.1 3.1 2.3 2.2 3.4 4.0
LIABILITIES
Accounts Payable 0.9 0.8 0.7 0.6 0.4 0.6 0.6 1.5 0.2 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 92.7 K 61.6 K 86.8 K 0.2 0.2 0.3 100 K 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0 0
Short Term Debt 2.1 1.1 0.9 0.9 1.3 1.3 0.3 0.1 0.1 0.2 0.2 0.2 0.2 42.4 K 0 0 0 0 0 0 0 0 22.3 K 20.5 K 18.7 K 0 0.2 0.2 0.2 100 K 0 0 0.2 100 K 100 K
Other Current Liabilities 1.0 1.2 0.9 0.7 0.8 0.6 1.1 0.4 0.5 0.4 0.3 0.3 0.3 0.4 0.7 0.4 0.2 (239.2) (44.1) 0.2 0.4 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.4 0.4
Total Current Liabilities 4.2 3.1 2.5 2.2 2.5 2.6 2.1 2.1 0.8 1.0 0.6 0.7 0.6 0.5 0.4 0.5 0.4 1.4 0.7 0.8 0.4 0.3 0.6 0.5 0.6 0.4 0.6 0.7 0.7 0.6 0.4 0.5 0.7 0.5 0.5
Long Term Debt 14.6 11.4 9.4 9.9 7.1 8.4 8.6 2.9 3.1 0.7 0.9 1.1 1.3 0.9 0 0 0 0 0.7 1.0 0.4 0.3 0.4 0.4 0.4 0.5 0.3 0.6 0.6 0.6 0.4 0 0 100 K 0
Deferred Tax Income 0 0 0 0 0 0 0 0 19.6 1 230.3 1 154.7 1 246.0 0 4.8 0 0 340.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 58.5 K 0 996 37.3 K 78.5 K 38.8 K 33 K 83.4 K 67.9 K 0 0 0 (340.0) 0 0 0 0 0 0.1 0 0 0 0 100 K 0 0 0 0 0 0 100 K
Total Liabilities 18.8 14.5 11.9 12.1 9.7 11.0 10.7 5.0 4.0 1.8 1.6 1.8 2.0 1.5 0.4 0.5 0.4 2.0 1.4 1.8 0.8 0.6 1.1 0.9 1.0 0.9 0.9 1.2 1.3 1.2 0.8 0.5 0.7 0.6 0.6
EQUITY
Common Stock 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0 0 0 0 0 0 0 0 0 0
Retained Earnings (12.0) (6.2) (3.7) (3.7) (2.6) (1.3) 1.0 1.1 0.6 (0.6) (0.4) (0.5) (0.6) (0.2) 0.2 0.4 0.9 0.2 (0.4) (0.6) (1.3) (1.7) (2.6) (3.0) (5.2) (5.8) (5.7) (5.9) (5.9) (5.9) (5.8) (5.7) (5.5) (4.1) (3.6)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 43.9 K 30.2 K 638 23.9 K 50.3 K 23.3 K 19.8 K 50.1 K 40.8 K 9.63 K (2.6) (2.3) (1.9) (2.0) (1.8) (1.5) (1.3) (1.1) (1.1) (1.0) (0.9) (0.8) (0.7) (0.6) (0.7) 0 0 0 0 0 0
Total Equity 25.0 30.4 32.6 28.3 29.0 21.7 23.6 19.7 10.6 9.3 9.4 9.2 9.0 9.3 9.6 9.6 10.1 9.3 8.6 7.7 7.4 7.0 6.0 5.5 2.8 2.2 2.3 1.9 1.9 1.9 2.3 1.8 1.5 2.8 3.4
Total Liabilities and Equity 43.8 44.9 44.5 40.4 38.7 32.7 34.3 24.7 14.6 11.1 11.0 11.0 11.0 10.8 10.0 10.1 10.4 11.4 10.0 9.5 8.2 7.5 7.1 6.4 3.9 3.1 3.2 3.1 3.2 3.1 3.1 2.3 2.2 3.4 4.0
SHARES OUTSTANDING
Common Shares Outstanding 7.7 7.7 7.6 7.2 6.8 5.5 4.9 4.2 3.0 3.0 3.0 3.0 3.0 3.0 3.0 2.9 2.9 2.9 2.8 2.8 2.7 2.8 2.8 2.6 2.4 2.4 2.7 2.7 2.3 1.7 2.6 1.8 2.0 2.1 2.0